Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-26-034268
Filing Date
2026-07-22
Accepted
2026-07-22 17:24:40
Documents
16
Effectiveness Date
2026-07-22

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 68376
2 EX-4.7 ex4-7.htm EX-4.7 180335
3 EX-5.1 ex5-1.htm EX-5.1 29583
4 EX-23.1 ex23-1.htm EX-23.1 3336
5 EX-23.2 ex23-2.htm EX-23.2 3449
6 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 16418
7 GRAPHIC ex5-1_001.jpg GRAPHIC 11657
  Complete submission text file 0001493152-26-034268.txt   438164

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5135
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297629 | Film No.: 261194552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)